In Vitro Characterization of Six Month Dosage Forms for a GnRH Antagonist
Figure 4
SEM of Formulation C during long-term in vitro release (37°C), at (a) day 0 (outer surface), (b) day 0 (higher magnification, fractured microspheres), and (c) day 180 (outer surface).
